Peter W Stacpoole MD
Diabetes, Lipid Metabolism
Professor, Medicine, University of Florida College of Medicine
Join to View Full Profile
1600 SW Archer RdGainesville, FL 32610
Dr. Stacpoole is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1980- Vanderbilt University Medical CenterResidency, Internal Medicine, 1976 - 1978
Vanderbilt University School of MedicineClass of 1976
UC San FranciscoPhD, Pharmacology, 1968 - 1972
Certifications & Licensure
CA State Medical License 1980 - Present
FL State Medical License 1981 - 2027
TN State Medical License 1978 - 1984
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
- Elected Member Royal Society of Physicians, 2000
- Elected Member The American Society for Clinical Investigation, 1985
Clinical Trials
- Prevention of Dichloroacetate Toxicity Start of enrollment: 2001 Sep 01
- Phase III Trial of Coenzyme Q10 in Mitochondrial Disease Start of enrollment: 2007 Jan 01
- Pharmacotoxicology of Trichloroethylene Metabolites Start of enrollment: 2011 Aug 01
Publications & Presentations
PubMed
- Should the "mitochondrial cocktail" be a default option? An opinion.Peter W Stacpoole, Stephen D Cederbaum
Molecular Genetics and Metabolism. 2025-12-01 - Pyruvate Dehydrogenase Complex Stimulation With Dichloroacetate May Improve Septic Cardiac Dysfunction.Lane M Smith, Yu Tin Lin, Chelsey S Mertens, Manal L Zabalawi, David L Long
Shock. 2025-12-01 - Extension of lifespan by epicatechin, halofuginone and mitoglitazone in male but not female genetically heterogeneous mice.Randy Strong, James F Nelson, Molly A Bogue, Jerry R Colca, Martin Denzel
Geroscience. 2025-09-19
Grant Support
- Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019UNIVERSITY OF FLORIDA2021–2025
- Personalized dosing of dichloroacetate for the treatment of rare and common diseasesMEDOSOME BIOTEC, LLC2017–2024
- Phase 3 Trial Of Coenzyme In Mitochondrial DiseaseFood And Drug Administration2006–2011
- Planning Grant For Phase 3 Trial Of Dichloroacetate In PDH DeficiencyEunice Kennedy Shriver National Institute Of Child Health &Human Development2010
- Pharmacotoxicology Of Trichloroethylene MetabolitesNational Institute Of Environmental Health Sciences2006–2010
Industry Relationships
- Chief Scientific Officer, Praesidio Pharma, LLCFocus on research involving dichloroacetate (DCA) and related compounds2018 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
